These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7687120)

  • 61. Quantitative structure-activity relationship studies of a series of sulfa drugs as inhibitors of Pneumocystis carinii dihydropteroate synthetase.
    Johnson T; Khan IA; Avery MA; Grant J; Meshnick SR
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1454-8. PubMed ID: 9624493
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pneumocystis jirovecii dihydropteroate synthase (DHPS) genotypes in non-HIV-immunocompromised patients: a tertiary care reference health centre study.
    Tyagi AK; Mirdha BR; Luthra K; Guleria R; Mohan A; Singh UB; Samantaray JC; Dar L; Iyer VK; Sreenivas V
    Med Mycol; 2011 Feb; 49(2):167-71. PubMed ID: 20718608
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The multifunctional folic acid synthesis fas gene of Pneumocystis carinii encodes dihydroneopterin aldolase, hydroxymethyldihydropterin pyrophosphokinase and dihydropteroate synthase.
    Volpe F; Ballantine SP; Delves CJ
    Eur J Biochem; 1993 Sep; 216(2):449-58. PubMed ID: 8397083
    [TBL] [Abstract][Full Text] [Related]  

  • 64. P-Aminobenzoic acid derivatives. Mode of action and structure-activity relationships in a cell-free system (Escherichia coli).
    Seydel JK; Butte W
    J Med Chem; 1977 Mar; 20(3):439-47. PubMed ID: 321779
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Dihydropteroate synthase polymorphisms in Pneumocystis carinii.
    Lane BR; Ast JC; Hossler PA; Mindell DP; Bartlett MS; Smith JW; Meshnick SR
    J Infect Dis; 1997 Feb; 175(2):482-5. PubMed ID: 9203679
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Absence of mutations associated with sulfa resistance in Pneumocystis carinii dihydropteroate synthase gene from non-human primates.
    Demanche C; Guillot J; Berthelemy M; Petitt T; Roux P; Wakefield AE
    Med Mycol; 2002 Jun; 40(3):315-8. PubMed ID: 12146763
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inhibition of dihydrofolate reductases from Toxoplasma gondii, Pneumocystis carinii, and rat liver by rotationally restricted analogues of pyrimethamine and metoprine.
    Rosowsky A; Queener SF; Cody V
    Drug Des Discov; 1999 Jul; 16(1):25-40. PubMed ID: 10466054
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cell-free dihydropteroate synthetase activity: its use to investigate the relationship between structure and activity of p-aminobenzoic derivatives.
    Thijssen HH
    Methods Enzymol; 1980; 66():570-6. PubMed ID: 6990197
    [No Abstract]   [Full Text] [Related]  

  • 69. Nonclassical 2,4-diamino-5-aryl-6-ethylpyrimidine antifolates: activity as inhibitors of dihydrofolate reductase from Pneumocystis carinii and Toxoplasma gondii and as antitumor agents.
    Robson C; Meek MA; Grunwaldt JD; Lambert PA; Queener SF; Schmidt D; Griffin RJ
    J Med Chem; 1997 Sep; 40(19):3040-8. PubMed ID: 9301666
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Classical and nonclassical furo[2,3-d]pyrimidines as novel antifolates: synthesis and biological activities.
    Gangjee A; Devraj R; McGuire JJ; Kisliuk RL; Queener SF; Barrows LR
    J Med Chem; 1994 Apr; 37(8):1169-76. PubMed ID: 8164259
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Phosphanilic acid inhibits dihydropteroate synthase.
    Eagon RG; McManus AT
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1936-8. PubMed ID: 2514624
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Absence of dihydropteroate synthase gene mutations in Pneumocystis jirovecii strains isolated from Aegean region of Turkey.
    Ozkoc S; Erguden C; Bayram Delibas S
    Parasitol Res; 2018 Oct; 117(10):3103-3108. PubMed ID: 30027382
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Conformationally restricted analogues of trimethoprim: 2,6-diamino-8-substituted purines as potential dihydrofolate reductase inhibitors from Pneumocystis carinii and Toxoplasma gondii.
    Gangjee A; Vasudevan A; Queener SF
    J Med Chem; 1997 Sep; 40(19):3032-9. PubMed ID: 9301665
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dihydropteroate synthase from Streptococcus pneumoniae: characterization of substrate binding order and sulfonamide inhibition.
    Vinnicombe HG; Derrick JP
    Biochem Biophys Res Commun; 1999 May; 258(3):752-7. PubMed ID: 10329458
    [TBL] [Abstract][Full Text] [Related]  

  • 75. 2,4-Diaminothieno[2,3-d]pyrimidine analogues of trimetrexate and piritrexim as potential inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase.
    Rosowsky A; Mota CE; Wright JE; Freisheim JH; Heusner JJ; McCormack JJ; Queener SF
    J Med Chem; 1993 Oct; 36(21):3103-12. PubMed ID: 8230096
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Increase in prevalence of Pneumocystis carinii mutations in patients with AIDS and P. carinii pneumonia, in the United States and China.
    Kazanjian PH; Fisk D; Armstrong W; Shulin Q; Liwei H; Ke Z; Meshnick S
    J Infect Dis; 2004 May; 189(9):1684-7. PubMed ID: 15116306
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in immunocompromised patients.
    Armstrong W; Meshnick S; Kazanjian P
    Microbes Infect; 2000 Jan; 2(1):61-7. PubMed ID: 10717542
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Evaluation of a new commercial real-time PCR assay for diagnosis of Pneumocystis jirovecii pneumonia and identification of dihydropteroate synthase (DHPS) mutations.
    Montesinos I; Delforge ML; Ajjaham F; Brancart F; Hites M; Jacobs F; Denis O
    Diagn Microbiol Infect Dis; 2017 Jan; 87(1):32-36. PubMed ID: 27789058
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Dihydropteroate Synthase (DHPS) Gene Mutations and Mitochondrial Large Subunit (mtLSU) rRNA Genotype Variations in Pneumocystis jirovecii Strains].
    Gülbudak H; Öztürk C; Kuyugöz S; Tezcan Ülger S
    Mikrobiyol Bul; 2021 Jan; 55(1):41-52. PubMed ID: 33590980
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Anti-Pneumocystis carinii activity of PS-15, a new biguanide folate antagonist.
    Hughes WT; Jacobus DP; Canfield C; Killmar J
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1417-9. PubMed ID: 8363369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.